BioHealth News Archive
Jonathan Aberman: It’s time to overcome our self-esteem problem – The Washington Post
Our region’s business community has a self-esteem problem. We nod shamefully when we are told we depend on government dollars for success. Wrong. {iframe}https://www.washingtonpost.com/news/capital-business/wp/2016/01/11/jonathan-aberman-its-time-to-overcome-our-self-esteem-problem/{/iframe}
Read More
Illumina Jumps into Cancer Screening with $100 Million Spin-off Grail | MIT Technology Review
The world’s largest DNA sequencing company says it will form a new company to develop blood tests that cost $1,000 or less and can…
Read More
Deloitte and AT&T Partner to Accelerate Adoption of Smart City Technology
Deloitte today announced a strategic alliance agreement with AT&T aimed at accelerating the adoption of smart city technology across U.S. cities. The telco and…
Read More
ETC names new AccelerateBaltimore class, adds an additional investment – Baltimore Business Journal
Six startups have been selected for the Emerging Technology Centers’ AccelerateBaltimore program and one will receive an extra investment of $100,000. Now in its…
Read More
OriGene Technologies Awarded Phase II SBIR Contract to Develop High-Affinity, Anti-Peptide Monoclonal Antibodies for SISCAPA Assays
OriGene Technologies, Inc. (OriGene), a leading manufacturer of high quality antibodies and gene-centric tools, announced today that they have been awarded a Phase II…
Read More
Hopkins grad student named to Forbes’ ’30 Under 30′ list – Baltimore Sun
Guy Marcus, a 24-year-old Ph.D. candidate in physics at the Johns Hopkins University, is one of 30 young scientists named to Forbes magazine's annual…
Read More
Here are the top venture capital recipients in Maryland through the first 9 months of 2015 – Baltimore Business Journal
As usual, we bring you the top five entries from our most recent list. This week, it's the top venture capital recipients in Maryland,…
Read More
Vtesse, Inc. Announces FDA’s Granting of Breakthrough Therapy Designation for VTS-270 in Niemann-Pick… — GAITHERSBURG, Md., Jan. 6, 2016 /PRNewswire/ —
Vtesse, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted its drug candidate, VTS-270 for treatment of Niemann-Pick Type C1…
Read More
Health care entrepreneur, Johns Hopkins graduate earns ‘Forbes’ distinction | Hub
David Narrow, who graduated from Johns Hopkins University in 2013 with a master's degree in biomedical engineering, has been named one of Forbes magazine's…
Read More
Accelerator Corporation Launches First Startup in New York City Portfolio – FierceBiotech
Accelerator Corporation, a leading life science investment and management firm, today announced the Series A financing of Petra Pharma Corporation to develop small molecule inhibitors for…
Read More
Under Armour’s collaboration with IBM Watson provide big data insights to advance connected fitness approach – MedCity NewsMedCity News
Under Armour’s partnership with IBM Watson is the latest in a series of announcements from the consumer health and fitness business that illustrate how…
Read More
Flatiron health raises $175 million from Roche – Business Insider
Nat Turner and Zach Weinberg are young, successful and ambitious. The pair formerly started an ad tech company that Google acquired for $81 million,…
Read More
Roche’s investment in tech companies – Business Insider
A cancer startup just raised millions in a funding round led by a pharmaceutical giant. That could be the sign of bigger things to…
Read More
Dana-Farber Spinout Grabs $73M, Plus Big Roche Deal, To Craft New Class Of Cancer Drugs – Forbes
Billions of dollars have been made from cancer drugs that inhibit the ubiquitin-proteasome system, otherwise known as the cellular garbage dump. By turning off…
Read More
Medigene AG announces key Management Changes | Medigene AG
Medigene AG (Frankfurt Stock Exchange: MDG1) announced today that the Supervisory Board has resolved important changes and additions to the senior management team to…
Read More